The antiinfective medicine sales in the UK are forecasted to show a steady increase from 2024 to 2028. In 2023, the value stood at 57.9 US Dollars Per Capita. Year-on-year variations highlight a consistent growth trend with a 1.39% increase from 2024 to 2025, followed by a 1.34% increase from 2025 to 2026. This upward trajectory continues with a 1.31% rise from 2026 to 2027, and a 1.26% improvement in 2028. Over the last two years, the aggregated percentage increase is 2.72%. The Compound Annual Growth Rate (CAGR) over the last five years, from 2023 to 2028, is approximately 1.31%.
Future trends to watch for include advancements in medical technologies, changing healthcare policies, and potential impacts from global health events, which could influence the demand and sales of antiinfective medicines in the UK. Monitoring changes in consumer behavior and emerging pathogens will be critical to understanding and capturing future market dynamics.
